Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Knowing where to keep your cash savings securely is essential for peace of mind. Explore the safest options available to you.
22,893 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
U.S. stocks rebound Tuesday after Monday’s tariff-driven drop, with the S&P 500 and Dow clawing back losses as invest...
A global race to control a nascent $320 billion brain-implant market pits Elon Musk and Sam Altman against Chinese ri...
European inflows into crypto funds contrast with U.S. outflows, as data shows Europe buying dips while US funds bleed...
A 2025 Courted study finds 16% of real estate agents switched brokerages, representing 230,000 movers and $590 billio...
Investors are eyeing the nascent field of quantum computing for dramatic upside. This guide breaks down three notable...
Saudi Aramco signals it could restore full output within days if Hormuz reopens, a development that investors are wat...
Morgan Stanley warns that aggressive policy moves and a fresh oil shock could jeopardize Republicans’ hold in the Sen...
Analysts say bitcoin’s price running same playbook is resurfacing, with a key $65,000 level in focus. A potential, if...
A Tuesday uptick in Edgewise Therapeutics stock topped the market, driven by an upbeat price target from a major bank...
China’s export engine and structural advantages are shaping a landscape where trade deals matter less than the decade...
Adobe is turning finance into an AI-powered operation, auto-responding 300,000 emails and halving contract-review tim...